{"count": 10, "results": [{"_id": "32723831", "pmid": 32723831, "pmcid": "PMC7722275", "title": "Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome", "journal": "RMD Open", "authors": ["Kuemmerle-Deschner JB", "Gautam R", "George AT", "Raza S", "Lomax KG", "Hur P"], "date": "2020-07-01T00:00:00Z", "doi": "10.1136/rmdopen-2020-001227", "meta_date_publication": "2020 Jul", "meta_volume": "6", "meta_issue": "2", "meta_pages": "", "score": 50273.234, "text_hl": "Among included studies, four were RCTs (@CHEMICAL_canakinumab @CHEMICAL_MESH:C541220 @@@canakinumab@@@, n=2 (@DISEASE_Cryopyrin_Associated_Periodic_Syndromes @DISEASE_MESH:D056587 @@@CAPS@@@, n=1; @DISEASE_Job_Syndrome @DISEASE_MESH:D007589 @@@HIDS@@@/@<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MKD@@@ and @DISEASE_Periodic_fever_familial_autosomal_dominant @DISEASE_MESH:C536657 @@@TRAPS@@@, n=1); rilonacept, n=1 (in @DISEASE_Cryopyrin_Associated_Periodic_Syndromes @DISEASE_MESH:D056587 @@@CAPS@@@); @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, n=1 (in @DISEASE_Job_Syndrome @DISEASE_MESH:D007589 @@@HIDS@@@/@<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MKD@@@)). ", "citations": {"NLM": "Kuemmerle-Deschner JB, Gautam R, George AT, Raza S, Lomax KG, Hur P. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome RMD Open. 2020 Jul;6(2):. PMID: 32723831", "BibTeX": "@article{32723831, title={Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome}, author={Kuemmerle-Deschner JB and Gautam R and George AT and Raza S and Lomax KG and Hur P}, journal={RMD Open}, volume={6}, number={2}}"}}, {"_id": "16722536", "pmid": 16722536, "pmcid": "PMC1475558", "title": "Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome", "journal": "Orphanet J Rare Dis", "authors": ["Haas D", "Hoffmann GF"], "date": "2006-04-26T00:00:00Z", "doi": "10.1186/1750-1172-1-13", "meta_date_publication": "2006 Apr 26", "meta_volume": "1", "meta_issue": "", "meta_pages": "13", "score": 50094.95, "text_hl": "There is no established successful treatment for @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MVA@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, an inhibitor of @GENE_HMGCR @GENE_3156 @@@HMG-CoA reductase@@@, and anakinra have been shown to have beneficial effect in @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@HIDS@@@.", "citations": {"NLM": "Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome Orphanet J Rare Dis. 2006 Apr 26;1():13. PMID: 16722536", "BibTeX": "@article{16722536, title={Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome}, author={Haas D and Hoffmann GF}, journal={Orphanet J Rare Dis}, volume={1}, pages={13}}"}}, {"_id": "19046710", "pmid": 19046710, "title": "A patient with hyper-IgD syndrome responding to simvastatin treatment.", "journal": "Eur J Intern Med", "authors": ["Attout H", "Guez S", "Ranaivo I", "Jameerbaccus N", "Series C"], "date": "2008-12-01T00:00:00Z", "doi": "10.1016/j.ejim.2008.04.009", "meta_date_publication": "2008 Dec", "meta_volume": "19", "meta_issue": "8", "meta_pages": "e82-3", "score": 50092.918, "text_hl": "A @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@hyper-IgD syndrome@@@ responding to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment.", "citations": {"NLM": "Attout H, Guez S, Ranaivo I, Jameerbaccus N, Series C. A patient with hyper-IgD syndrome responding to simvastatin treatment. Eur J Intern Med. 2008 Dec;19(8):e82-3. PMID: 19046710", "BibTeX": "@article{19046710, title={A patient with hyper-IgD syndrome responding to simvastatin treatment.}, author={Attout H and Guez S and Ranaivo I and Jameerbaccus N and Series C}, journal={Eur J Intern Med}, volume={19}, number={8}, pages={e82-3}}"}}, {"_id": "27652005", "pmid": 27652005, "pmcid": "PMC5005254", "title": "Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition", "journal": "Springerplus", "authors": ["Suzuki N", "Ito T", "Matsui H", "Takizawa M"], "date": "2016-08-30T00:00:00Z", "doi": "10.1186/s40064-016-3125-1", "meta_date_publication": "2016", "meta_volume": "5", "meta_issue": "1", "meta_pages": "1429", "score": 50090.35, "text_hl": "@CELLLINE_CVCL:0006 @@@THP-1@@@ cells were pretreated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (4 mumol/L) for 24 h in order to induce @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MKD@@@-like phenotype by reducing endogenous @GENE_MAFD2 @GENE_4096 @@@MDI@@@ levels (Galeotti et al.). ", "citations": {"NLM": "Suzuki N, Ito T, Matsui H, Takizawa M. Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition Springerplus. 2016;5(1):1429. PMID: 27652005", "BibTeX": "@article{27652005, title={Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition}, author={Suzuki N and Ito T and Matsui H and Takizawa M}, journal={Springerplus}, volume={5}, number={1}, pages={1429}}"}}, {"_id": "15116060", "pmid": 15116060, "title": "Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.", "journal": "Clin Pharmacol Ther", "authors": ["Simon A", "Drewe E", "van der Meer JW", "Powell RJ", "Kelley RI", "Stalenhoef AF", "Drenth JP"], "date": "2004-05-01T00:00:00Z", "doi": "10.1016/j.clpt.2004.01.012", "meta_date_publication": "2004 May", "meta_volume": "75", "meta_issue": "5", "meta_pages": "476-83", "score": 50080.29, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment for @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory attacks@@@ of the @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@hyperimmunoglobulinemia D@@@ and @DISEASE_Hereditary_Autoinflammatory_Diseases @DISEASE_MESH:D056660 @@@periodic fever syndrome@@@.", "citations": {"NLM": "Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004 May;75(5):476-83. PMID: 15116060", "BibTeX": "@article{15116060, title={Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.}, author={Simon A and Drewe E and van der Meer JW and Powell RJ and Kelley RI and Stalenhoef AF and Drenth JP}, journal={Clin Pharmacol Ther}, volume={75}, number={5}, pages={476-83}}"}}, {"_id": "18506569", "pmid": 18506569, "title": "Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.", "journal": "Clin Rheumatol", "authors": ["Topaloğlu R", "Ayaz NA", "Waterham HR", "Yüce A", "Gumruk F", "Sanal O"], "date": "2008-10-01T00:00:00Z", "doi": "10.1007/s10067-008-0911-3", "meta_date_publication": "2008 Oct", "meta_volume": "27", "meta_issue": "10", "meta_pages": "1317-20", "score": 50076.527, "text_hl": "There is no consensus for specific therapy of @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@HIDS@@@, but there are some case reports and studies in regards to its treatment with drugs like @CHEMICAL_Colchicine @CHEMICAL_MESH:D003078 @@@colchicine@@@, @CHEMICAL_Steroids @CHEMICAL_MESH:D013256 @@@steroids@@@, nonsteroid anti-inflammatory drugs, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, anakinra, @CHEMICAL_Thalidomide @CHEMICAL_MESH:D013792 @@@thalidomide@@@, and etanercept. ", "citations": {"NLM": "Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol. 2008 Oct;27(10):1317-20. PMID: 18506569", "BibTeX": "@article{18506569, title={Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.}, author={Topaloğlu R and Ayaz NA and Waterham HR and Yüce A and Gumruk F and Sanal O}, journal={Clin Rheumatol}, volume={27}, number={10}, pages={1317-20}}"}}, {"_id": "18941711", "pmid": 18941711, "title": "Hyper-IgD syndrome with novel mutation in a Japanese girl.", "journal": "Mod Rheumatol", "authors": ["Naruto T", "Nakagishi Y", "Mori M", "Miyamae T", "Imagawa T", "Yokota S"], "date": "2009-01-01T00:00:00Z", "doi": "10.1007/s10165-008-0130-4", "meta_date_publication": "2009", "meta_volume": "19", "meta_issue": "1", "meta_pages": "96-9", "score": 50076.105, "text_hl": "@<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@Hyper-IgD syndrome@@@ with novel mutation in a Japanese girl.", "citations": {"NLM": "Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S. Hyper-IgD syndrome with novel mutation in a Japanese girl. Mod Rheumatol. 2009;19(1):96-9. PMID: 18941711", "BibTeX": "@article{18941711, title={Hyper-IgD syndrome with novel mutation in a Japanese girl.}, author={Naruto T and Nakagishi Y and Mori M and Miyamae T and Imagawa T and Yokota S}, journal={Mod Rheumatol}, volume={19}, number={1}, pages={96-9}}"}}, {"_id": "20814828", "pmid": 20814828, "pmcid": "PMC2946549", "title": "Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency", "journal": "J Inherit Metab Dis", "authors": ["Henneman L", "Schneiders MS", "Turkenburg M", "Waterham HR"], "date": "2010-10-01T00:00:00Z", "doi": "10.1007/s10545-010-9173-8", "meta_date_publication": "2010 Oct", "meta_volume": "33", "meta_issue": "5", "meta_pages": "625-32", "score": 50073.625, "text_hl": "In contrast, treatment of six @SPECIES_9606 @@@patients@@@ with a milder @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MKD@@@:i.e. hyper-@<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@IgD syndrome@@@:with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (Simon et al) did not provoke clinical crises. ", "citations": {"NLM": "Henneman L, Schneiders MS, Turkenburg M, Waterham HR. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency J Inherit Metab Dis. 2010 Oct;33(5):625-32. PMID: 20814828", "BibTeX": "@article{20814828, title={Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency}, author={Henneman L and Schneiders MS and Turkenburg M and Waterham HR}, journal={J Inherit Metab Dis}, volume={33}, number={5}, pages={625-32}}"}}, {"_id": "18684863", "pmid": 18684863, "title": "HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.", "journal": "Blood", "authors": ["Kuijk LM", "Beekman JM", "Koster J", "Waterham HR", "Frenkel J", "Coffer PJ"], "date": "2008-11-01T00:00:00Z", "doi": "10.1182/blood-2008-03-144667", "meta_date_publication": "2008 Nov 1", "meta_volume": "112", "meta_issue": "9", "meta_pages": "3563-73", "score": 50072.723, "text_hl": "Here we show that inhibition of @GENE_HMGCR @GENE_3156 @@@HMG-CoA reductase@@@ by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment, mimicking @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@MKD@@@, results in increased @GENE_IL1B @GENE_3553 @@@IL-1beta@@@ secretion in a @GENE_RAC1 @GENE_5879 @@@Rac1@@@/PI3K-dependent manner. ", "citations": {"NLM": "Kuijk LM, Beekman JM, Koster J, Waterham HR, Frenkel J, Coffer PJ. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood. 2008 Nov 1;112(9):3563-73. PMID: 18684863", "BibTeX": "@article{18684863, title={HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.}, author={Kuijk LM and Beekman JM and Koster J and Waterham HR and Frenkel J and Coffer PJ}, journal={Blood}, volume={112}, number={9}, pages={3563-73}}"}}, {"_id": "16093577", "pmid": 16093577, "title": "Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.", "journal": "Neth J Med", "authors": ["Bodar EJ", "van der Hilst JC", "Drenth JP", "van der Meer JW", "Simon A"], "date": "2005-07-01T00:00:00Z", "meta_date_publication": "2005 Jul-Aug", "meta_volume": "63", "meta_issue": "7", "meta_pages": "260-4", "score": 50066.055, "text_hl": "Treatment of @<m>DISEASE_Mevalonate_Kinase_Deficiency</m> @DISEASE_MESH:D054078 @@@HIDS@@@ is difficult, although @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is beneficial and etanercept might be effective. ", "citations": {"NLM": "Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005 Jul-Aug;63(7):260-4. PMID: 16093577", "BibTeX": "@article{16093577, title={Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.}, author={Bodar EJ and van der Hilst JC and Drenth JP and van der Meer JW and Simon A}, journal={Neth J Med}, volume={63}, number={7}, pages={260-4}}"}}]}